ViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19

Press/Media: Expert Comment

PeriodJul 8 2020

Media coverage

3

Media coverage

  • TitleViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletCorporate IT Update
    Country/TerritoryUnited States
    Date7/8/20
    PersonsCheng Huang, John Manning
  • TitleViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletM2 Pharma
    Country/TerritoryUnited States
    Date7/8/20
    PersonsCheng Huang, John Manning
  • TitleViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletM2Pharma.com
    Country/TerritoryUnited States
    Date7/8/20
    URLm2pharma.com/news/policy-and-regulations/article.php?id=86319
    PersonsCheng Huang, John Manning

Keywords

  • COVID-19